These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Atrial fibrillation and embolism. Milliken JA Can Med Assoc J; 1983 Jun; 128(12):1370-2. PubMed ID: 6850461 [No Abstract] [Full Text] [Related]
24. [The assessment of the thromboembolic risk and the role of antithrombotic prophylaxis in nonrheumatic atrial fibrillation]. Fera MS; Giovannini E G Ital Cardiol; 1999 Feb; 29(2):193-213. PubMed ID: 10088078 [No Abstract] [Full Text] [Related]
25. [The current indications for antithrombotic treatment in valve disease]. del Río del Busto A; Pardo Vigo A Rev Esp Cardiol; 1991 Mar; 44(3):190-202. PubMed ID: 2047549 [No Abstract] [Full Text] [Related]
26. [Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy]. Codinach Huix P Med Clin (Barc); 1996 Apr; 106(15):586-9. PubMed ID: 8656759 [No Abstract] [Full Text] [Related]
27. [New agents and challenges in the antithrombotic management of arterial diseases]. Udvardy M; Rák K Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617 [TBL] [Abstract][Full Text] [Related]
28. Antithrombotic therapy for stroke prevention among Medicare beneficiaries hospitalized in Alaska with atrial fibrillation. Gordian ME; Mustin HD Alaska Med; 1998; 40(4):79-84. PubMed ID: 10202404 [TBL] [Abstract][Full Text] [Related]
29. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Flaker GC; McGowan DJ; Boechler M; Fortune G; Gage B Am Heart J; 1999 Feb; 137(2):307-12. PubMed ID: 9924165 [TBL] [Abstract][Full Text] [Related]
31. [Clinical characteristics and antithrombotic therapy for stroke prevention in patients with atrial fibrillation]. Tsuzuki N Hokkaido Igaku Zasshi; 2002 Nov; 77(6):563-70. PubMed ID: 12491628 [No Abstract] [Full Text] [Related]
32. Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation. Marchant BG; Timmis AD Br J Hosp Med; 1993 Feb 3-16; 49(3):186-90. PubMed ID: 8439785 [TBL] [Abstract][Full Text] [Related]
33. Antithrombotic management of atrial fibrillation for stroke prevention in older people. Tong DC; Albers GW Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928 [TBL] [Abstract][Full Text] [Related]
34. Antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Wellman M; Martin AC J Fam Pract; 1999 Jul; 48(7):498. PubMed ID: 10428244 [No Abstract] [Full Text] [Related]
35. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564 [TBL] [Abstract][Full Text] [Related]
36. Antithrombotic treatment in chronic non-rheumatic atrial fibrillation. ten Bokkel Huinink D; de Meijer PH Neth J Med; 1997 Aug; 51(2):51-6. PubMed ID: 9286141 [No Abstract] [Full Text] [Related]
37. Antithrombotic therapy in atrial fibrillation. Venes D Chest; 1993 Dec; 104(6):1939-40. PubMed ID: 8253002 [No Abstract] [Full Text] [Related]
38. Medical revolution: the prevention and treatment of stroke, 1996. Part 2. Medical prevention of stroke and acute stroke therapy. Kirshner HS Tenn Med; 1996 Nov; 89(11):410-2. PubMed ID: 8942279 [No Abstract] [Full Text] [Related]
39. Anticoagulation in nonvalvular atrial fibrillation. Borresen T J La State Med Soc; 1996 Nov; 148(11):479-84. PubMed ID: 8990787 [TBL] [Abstract][Full Text] [Related]
40. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]